#drugdiscovery

ISNTD Infectious Thoughts

Dr. Eliana Nakano (Instituto Butantan São Paulo)

By searching for new compounds to schistosomiasis control, we aim to increase the current chemical arsenal available for this disease.

Dr. Bonnie Webster (Natural History Museum London): Molecular diagnostics for schistosomiasis

At ISNTD d³ 2017, Dr. Bonnie Webster from the Natural History Museum London speaks about recent research at the NHM to develop molecular dia

Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention): Ebola & Filoviruses Vaccine Devel

At ISNTD d³ 2017, Dr. Valerie Oriol Mathieu, Global Medical Affairs Lead at Janssen Vaccines & Prevention, speaks about current challeng

Infectious Thoughts Interview: Enwono Eyoh (University of Edinburgh)

Enwono Eyoh speaks to the ISNTD about current research at the University of Edinburgh's Parasite Immuno-epidemiology group on a vaccine

Infectious Thoughts Interview: Dr. Benny Baeten (Johnson & Johnson)

Dr. Benny Baeten, Compound Development Team Leader for Anthelmintics at the Janssen Pharmaceutical Companies of Johnson & Johnson speaks

Panel discussion: Current gaps & research priorities for NTD drug discovery May 2017

Panel discussion at ISNTD d³ 2017, chaired by Mr. Duc H. Le, Editor in Chief at EBio Medicine. Panelists are: • Dr. Benny Baeten (J&J...

Dr. Stephan Goetz (Iceni Diagnostics): Carbohydrate diagnostics for infectious diseases

At the ISNTD d³ 2017 conference, Dr. Stephan Goetz, senior scientists at Iceni Diagnostics, speaks about the potential of carbohydrate diagn

Dr. Rita Oliveira (Imperial College London): Comparing standard and molecular diagnostics for STH

At ISNTD d³ 2017, Dr. Rita Oliveira, from Imperial College London, speaks about recent community-wide cross sectional study of Soil-Transmit

Dr. Victor del Rio Vilas (University of Surrey): The road to rabies elimination

At ISNTD d³ 2017, Dr. Victor del Rio Vilas (University of Surrey) speaks about "Inter-laboratory proficiency exercises and data integra

Pr. Simon Croft (LSHTM) Designing new treatments for leishmaniasis

A virtual biobank to accelerate NTD diagnostics development: an Infectious Thoughts interview

Tackling dengue in Pakistan: an Infectious Thoughts interview

Unprecedented dengue in Nepal: Myths & Misunderstandings

Country experience: dengue in Ethiopia

Takeda opens new dengue vaccine manufacturing plant in Singen, Germany

Kayla de Freitas (Guyana): dengue in Guyana, collective experiences

Assessing the repellent efficacy of essential oils

They signed the World Dengue Day petition: find out why

Understanding patient mobility patterns to tackle dengue transmission

In the frontline: Disease Control Agents' role, an insight from Brazil